Data as of Dec 06
| +0.29 / +0.93%|
The 18 analysts offering 12-month price forecasts for Pfizer Inc have a median target of 33.51, with a high estimate of 36.00 and a low estimate of 27.00. The median estimate represents a +6.24% increase from the last price of 31.54.
The current consensus among 22 polled investment analysts is to Buy stock in Pfizer Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.